140 related articles for article (PubMed ID: 30099761)
21. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
23. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
[TBL] [Abstract][Full Text] [Related]
24. CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.
Suh SH; Choi HS; Kim CS; Kim IJ; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098220
[TBL] [Abstract][Full Text] [Related]
25. HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity.
Kee HJ; Bae EH; Park S; Lee KE; Suh SH; Kim SW; Jeong MH
Kidney Blood Press Res; 2013; 37(4-5):229-39. PubMed ID: 23868068
[TBL] [Abstract][Full Text] [Related]
26. MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
Oeing CU; Jun S; Mishra S; Dunkerly-Eyring BL; Chen A; Grajeda MI; Tahir UA; Gerszten RE; Paolocci N; Ranek MJ; Kass DA
Circ Res; 2021 Mar; 128(5):639-651. PubMed ID: 33401933
[TBL] [Abstract][Full Text] [Related]
27. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
28. Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.
Pereyra AS; Hasek LY; Harris KL; Berman AG; Damen FW; Goergen CJ; Ellis JM
J Biol Chem; 2017 Nov; 292(45):18443-18456. PubMed ID: 28916721
[TBL] [Abstract][Full Text] [Related]
29. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter.
Blais M; Désilets A; Asselin C
DNA Cell Biol; 2005 Apr; 24(4):209-17. PubMed ID: 15812237
[TBL] [Abstract][Full Text] [Related]
30. Suberoylanilide Hydroxamic Acid Restores Estrogen Reduced-cTnI Expression in Neonatal Hearts of Mice.
Peng C; Luo X; Xing Q; Sun H; Huang X
J Cell Biochem; 2016 Oct; 117(10):2377-84. PubMed ID: 27379430
[TBL] [Abstract][Full Text] [Related]
31. TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
Ogórek B; Lam HC; Khabibullin D; Liu HJ; Nijmeh J; Triboulet R; Kwiatkowski DJ; Gregory RI; Henske EP
Hum Mol Genet; 2018 May; 27(9):1654-1663. PubMed ID: 29509898
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.
Zhan J; Chitta RK; Harwood FC; Grosveld GC
Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133
[TBL] [Abstract][Full Text] [Related]
33. Regulation of TSC2 lysosome translocation and mitochondrial turnover by TSC2 acetylation status.
Marqués P; Burillo J; González-Blanco C; Jiménez B; García G; García-Aguilar A; Iglesias-Fortes S; Lockwood Á; Guillén C
Sci Rep; 2024 May; 14(1):12521. PubMed ID: 38822085
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic modulation with HDAC inhibitor CG200745 induces anti-proliferation in non-small cell lung cancer cells.
Chun SM; Lee JY; Choi J; Lee JH; Hwang JJ; Kim CS; Suh YA; Jang SJ
PLoS One; 2015; 10(3):e0119379. PubMed ID: 25781604
[TBL] [Abstract][Full Text] [Related]
35. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
36. Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy.
Davogustto GE; Salazar RL; Vasquez HG; Karlstaedt A; Dillon WP; Guthrie PH; Martin JR; Vitrac H; De La Guardia G; Vela D; Ribas-Latre A; Baumgartner C; Eckel-Mahan K; Taegtmeyer H
J Mol Cell Cardiol; 2021 Sep; 158():115-127. PubMed ID: 34081952
[TBL] [Abstract][Full Text] [Related]
37. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
[TBL] [Abstract][Full Text] [Related]
38. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility.
Davis FJ; Pillai JB; Gupta M; Gupta MP
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1477-90. PubMed ID: 15388503
[TBL] [Abstract][Full Text] [Related]
39. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
